Debt & credit overview

As a basis for and contribution to effective risk management and to ensure that the company will be able to pursue its strategies even during periods of economic downturn, Koninklijke DSM N.V. retains a?solid financial policy.

The company aims to maintain a strong investment grade long-term credit rating for senior unsecured debt; most external funding needs being financed through long-term debt.?DSM also has a commercial paper program and?revolving committed credit facilities.

DSM’s credit is only rated by S&P Global Ratings (S&P) and Moody’s to which DSM provides accurate information necessary for their rating analyses, such as our management strategy, financial policies and financing matters.

DSM has not obtained a credit rating from Scope and DSM has not provided any information to Scope. Therefore Scope’s unsolicited opinions and publications regarding DSM are based on their subjective assumptions and hypotheses with no reasonable basis for support.

DSM aims to spread the maturity profile of outstanding bonds in order to have adequate financial flexibility. The average effective interest rate on the portfolio of borrowings outstanding in 2022, including hedge instruments related to these borrowings, amounted to 1.90% (2021: 1.86%).

Debt covenants are not included in the terms and conditions of outstanding bonds and financing arrangements.

DSM holds a €1.0 billion revolving committed credit facility (RCF), which serves as back-up funding.?The interest rate of this RCF is linked to DSM's Greenhouse Gas (GHG) emission reductions.

Royal DSM's Euro Commercial Paper Program is a framework with standard terms and conditions which are applicable if Notes are issued. The Euro Commercial Paper Program is not quoted on a Stock Exchange. The terms & conditions of this program are laid down in the?Memorandum.

?

Legal disclaimer
This website contains information and documents which are for information purposes only. They neither constitute an offer nor an invitation nor a recommendation to subscribe to or to purchase, to hold or sell securities, nor are the information or documents contained on this website meant to serve as a basis for any kind of obligation, contractual or otherwise.

Publication of prospectuses on this website is done in accordance with legal requirements in connection with the admission to trading of securities.

Distribution of information and documents contained on this website, especially prospectuses, may be forbidden or limited by legislation of some jurisdictions.

Access is denied to persons to whom these restrictions in such jurisdictions apply. Each visitor to this website is required to inform himself accordingly and to comply with applicable restrictions. Koninklijke DSM N.V. is in no way liable for any such infringement.

THE INFORMATION AND DOCUMENTS CONTAINED ON THIS WEBSITE ARE NOT DIRECTED AT AND MAY NOT BE VIEWED BY OR DISTRIBUTED TO ANY PERSON RESIDENT IN THE UNITED STATES OF AMERICA.

By entering the following parts of this website you confirm that you are not a resident of the United States of America and that you will not distribute any of the information and documents contained thereon to any person resident in the United States of America.

You further acknowledge that the following information and documents neither constitute an offer nor an invitation nor a recommendation to subscribe to or to purchase, to hold or sell securities.